Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pajares

Showing results (911-920 of 1,065) with videos related to

Pageof 107
Sort By:
Frontiers in Oncology|December 3, 2025
Real-world data analysis of adjuvant capecitabine for triple-negative breast cancer after neoadjuvant chemotherapyAna Godoy-Ortíz, Gonzalo Lendínez-Sánchez, Manuel Zalabardo, et al.
Clinical Genetics|April 30, 2023
Evolution of clinical and radiological presentations of spondyloepimetaphyseal dysplasia, RPL13-related: Description of 11 further casesFrancisca Díaz-González, Manuel Parrón-Pajares, Elsa Lucas-Castro, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 31, 2016
Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic valueE Alegre, J P Fusco, P Restituto, et al.
Nature Methods|August 4, 2022
PROBER identifies proteins associated with programmable sequence-specific DNA in living cellsSmarajit Mondal, Muthukumar Ramanathan, Weili Miao, et al.
Medrxiv : the Preprint Server for Health Sciences|May 25, 2021
Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19Alec A Schmaier, Gabriel Pajares Hurtado, Zachary J Manickas-Hill, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 3, 2021
Incidence of COVID-19 in 902 Patients With Immunomediated Inflammatory Diseases Treated With Biologics and Targeted Synthetic Disease-Modifying Antirheumatic Drugs-Findings From the BIOCOVID StudySantiago Muñoz-Fernández, Laura Cebrian, Israel John Thuissard, et al.
Elife|June 28, 2021
Developing a multivariate prediction model of antibody features associated with protection of malaria-infected pregnant women from placental malariaElizabeth H Aitken, Timon Damelang, Amaya Ortega-Pajares, et al.
Scientific Reports|October 30, 2019
Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1Maria Villalba, Esther Redin, Francisco Exposito, et al.
Oncotarget|July 5, 2022
Role of germline variants in the metastasis of breast carcinomasÁngela Santonja, Aurelio A Moya-García, Nuria Ribelles, et al.
Open Respiratory Archives|August 2, 2024
Malignant Pleural Effusion: A Multidisciplinary ApproachAna Pardessus Otero, Albert Rafecas-Codern, José M Porcel, et al.
Pageof 107

Showing results (911-920 of 1,065) with videos related to

Sort By:
Pageof 107
Frontiers in Oncology|December 3, 2025
Real-world data analysis of adjuvant capecitabine for triple-negative breast cancer after neoadjuvant chemotherapyAna Godoy-Ortíz, Gonzalo Lendínez-Sánchez, Manuel Zalabardo, et al.
Clinical Genetics|April 30, 2023
Evolution of clinical and radiological presentations of spondyloepimetaphyseal dysplasia, RPL13-related: Description of 11 further casesFrancisca Díaz-González, Manuel Parrón-Pajares, Elsa Lucas-Castro, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 31, 2016
Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic valueE Alegre, J P Fusco, P Restituto, et al.
Nature Methods|August 4, 2022
PROBER identifies proteins associated with programmable sequence-specific DNA in living cellsSmarajit Mondal, Muthukumar Ramanathan, Weili Miao, et al.
Medrxiv : the Preprint Server for Health Sciences|May 25, 2021
Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19Alec A Schmaier, Gabriel Pajares Hurtado, Zachary J Manickas-Hill, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 3, 2021
Incidence of COVID-19 in 902 Patients With Immunomediated Inflammatory Diseases Treated With Biologics and Targeted Synthetic Disease-Modifying Antirheumatic Drugs-Findings From the BIOCOVID StudySantiago Muñoz-Fernández, Laura Cebrian, Israel John Thuissard, et al.
Elife|June 28, 2021
Developing a multivariate prediction model of antibody features associated with protection of malaria-infected pregnant women from placental malariaElizabeth H Aitken, Timon Damelang, Amaya Ortega-Pajares, et al.
Scientific Reports|October 30, 2019
Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1Maria Villalba, Esther Redin, Francisco Exposito, et al.
Oncotarget|July 5, 2022
Role of germline variants in the metastasis of breast carcinomasÁngela Santonja, Aurelio A Moya-García, Nuria Ribelles, et al.
Open Respiratory Archives|August 2, 2024
Malignant Pleural Effusion: A Multidisciplinary ApproachAna Pardessus Otero, Albert Rafecas-Codern, José M Porcel, et al.
Pageof 107